|
|
|
Corporate Profile: Callisto
Pharmaceuticals
| Summary: |
Callisto Pharmaceuticals
is involved in the development of drugs to treat gastrointestinal disorders and diseases, rheumatoid arthritis, neuroendocrine cancer, and acute leukemia. |
| Address: |
420 Lexington Avenue
Suite 1609
New York, NY 10170 |
700 East Butler Avenue
Doylestown, PA 18901 |
| Phone
#'s: |
Main |
(212) 297-0010 |
(215) 589-6308
|
| Human Resources |
not known |
not known |
| Investor Relations |
not known |
not known |
| Fax
#'s: |
Main |
(212) 297-0020 |
(215) 489-4920 |
| Human Resources |
not known |
not known |
| Investor Relations |
not known |
not known |
| email: |
Main |
not known |
| Human Resources |
not known |
| Investor Relations |
not known |
| Financial
information: |
| CLSP |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
